Bank Syariah Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Syariah Indonesia Tbk trades at Rp1,730 (market cap 79.23T, 9.56M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bank Syariah Indonesia Tbk is far larger — about 255× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Syariah Indonesia Tbk is more actively traded (9.56M versus 963.6K). Which is the better fit depends on your goals.
| BRIS | DGNS | |
|---|---|---|
Market Cap | 79.23T | 310.75B |
Volume | 9.56M | 963.6K |
Lot | 95.64K | 9.64K |
Turnover | 16.64B | 217.67M |
Average Price | 1,740 | 225.89 |
Value | 16.64B | 217.67M |
Indicative Equilibrium Price | 1,730 | 226 |
Indicative Equilibrium Volume | 9.17K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank BRISyariah Tbk (the Bank) is located in Jakarta, Indonesia, and initially established under the name of PT Bank Jasa Arta (BJA) based on the Deed of Establishment No. 4 dated April 3, 1969 of Liem Toeng Kie, S.H., Notary in Jakarta.
Read more on BRIS →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →